HKU Scholars Hub: Browsing DSpace

Browsing by Author Peng, CY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 14 to 24 of 24 < previous

	Title	Author(s)	Issue Date	Views
	Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013	Tak, WY Lin, SM Wang, Y Zheng, J Izzo, F Park, SY Chen, MH Wong, SN Xu, R Peng, CY Chiou, YY Huang, GT Lee, JY Sherman, M Abdullah, BJJ Lee, JS Wang, JH Borys, N Poon, RTP Lencioni, R	-	53
	Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine Journal:Clinical Gastroenterology and Hepatology	Park, J Le, AK Tseng, TC Yeh, ML Jun, DW Trinh, H Wong, GLH Cheng, CH Peng, CY Kim, SE Oh, H Kwak, MS Cheung, KSM Toyoda, H Hsu, YC Jeong, JY Yoon, EL Ungtrakul, T Zhang, J Xie, Q Ahn, SB Enomoto, M Shim, JJ Cunningham, C Jeong, SW Cho, YK Ogawa, E Huang, R Lee, DH Takahashi, H Tsai, PC Huang, CF Dai, CY Tseng, CH Yasuda, S Kozuka, R Li, J Wong, C Wong, CC Zhao, C Hoang, J Eguchi, Y Wu, C Tanaka, Y Gane, E Tanwandee, T Cheung, R Yuen, RMF Lee, HS Yu, ML Kao, JH Yang, HI Nguyen, MH	2021	14
	REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) - A Risk Score for the Prediction of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis (CHB) Patients Treated with Oral Anti-HBV Therapy Proceeding/Conference:Hepatology	Nguyen, MH Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KSM Su, TH Kozuka, R Ogawa, E Li, J Zhang, JQ Wong, C Wong, Clifford Prasad, D Hoang, J Lin, CH Ueno, Y Gane, EJ Xing, H Furusyo, N Enomoto, M Kao, JH Yuen, RMF Yu, ML	2017	207
	Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy Journal:The Journal of Infectious Diseases	Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KS Xie, Q Su, TH Kozuka, R Lee, DH Ogawa, E Zhao, C Ning, HB Huang, R Li, J Zhang, JQ Ide, T Xing, H Iwane, S Takahashi, H Wong, C Wong, C Lin, CH Hoang, J Le, A Henry, L Toyoda, H Ueno, Y Gane, EJ Eguchi, Y Kurosaki, M Wu, C Liu, C Shang, J Furusyo, N Enomoto, M Kao, JH Yuen, MF Yu, ML Nguyen, MH	2020	33
	Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:The Liver Meeting® 2016	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, K Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2016	52
	Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017	Seto, WKW Asahina, Y Peng, CY Stanciu, C Abdurakhmanov, D Flaherty, J Kim, L Gaggar, A Subramanian, M Tabak, F Nguyen, TT Chan, HLY	2017	38
	RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology	Seto, WKW Asahina, Y Brown, TT Peng, CY Stanciu, C Abdurakhmanov, D Tabak, F Nguyen, TT Chuang, WL Inokuma, T Ikeda, F Santantonio, TA Habersetzer, F Ramji, A Lau, AH Suri, V Flaherty, JF Wang, H Gaggar, A Subramanian, GM Mukewar, S Brunetto, MR Fung, S Chan, HL	2018	50
	Tenofovir versus entecavir for hepatocellular Carcinoma prevention in an international consortium of chronic hepatitis B Proceeding/Conference:Hepatology	Hsu, YC Wong, GLH Chen, CH Peng, CY Yeh, ML Cheung, KSM Toyoda, H Huang, CF Trinh, HN Xie, Q Enomoto, M Liu, L Yasuda, S Tanaka, Y Kozuka, R Tsai, PC Huang, YT Huang, R Jang, TY Hoang, J Yang, HI Li, J Lee, DH Takahashi, H Zhang, JQ Ogawa, E Zhao, CQ Liu, CH Furusyo, N Eguchi, Y Wong, C Wong, C Wu, C Kumada, T Yuen, RMF Yu, ML Nguyen, MH	2019	26
	Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B Journal:The American Journal of Gastroenterology	Hsu, YC Wong, GLH Chen, CH Peng, CY Yeh, ML Cheung, KS Toyoda, H Huang, CF Trinh, H Xie, Q Enomoto, M Liu, L Yasuda, S Tanaka, Y Kozuka, R Tsai, PC Huang, YT Wong, C Huang, R Jang, TY Hoang, J Yan, HI Li, J Lee, DH Takahashi, H Zhang, JQ Ogawa, E Zhao, C Liu, C Furusyo, N Eguchi, Y Wong, C Wu, C Kumada, T Yuen, MF Yu, ML Nguyen, M	2020	28
	Ternary Ni–Co–P nanoparticles as noble-metal-free catalysts to boost the hydrolytic dehydrogenation of ammonia-borane Journal:Energy & Environmental Science	Hou, CC Li, Q Wang, CJ Peng, CY Chen, QQ Ye, HF Fu, WF Che, CM Núria, L Chen, Y	2017	78
	Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients Journal:Hepatology International	Liu, M Tseng, TC Jun, DW Yeh, ML Trinh, H Wong, GLH Chen, CH Peng, CY Kim, SE Oh, H Kwak, MS Cheung, M Toyoda, H Hsu, YC Jeong, JY Yoon, EL Ungtrakul, T Zhang, J Xie, Q Ahn, SB Enomoto, M Shim, JJ Cunningham, C Jeong, SW Cho, YK Ogawa, E Huang, R Lee, DH Takahashi, H Tsai, PC Huang, CF Dai, CY Tseng, CH Yasuda, S Kozuka, R Li, J Wong, C Wong, CC Zhao, C Hoang, J Eguchi, Y Wu, C Tanaka, Y Gane, E Tanwandee, T Cheung, R Yuen, MF Lee, HS Yu, ML Kao, JH Yang, HI Nguyen, MH	2021	11

Showing results 14 to 24 of 24 < previous